Patents by Inventor Ao Li

Ao Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220344490
    Abstract: A system and methods of manufacturing semiconductor devices is described herein. The method includes forming a recess between fins in a substrate and forming a dielectric layer over the fins and in the recess. Once the dielectric layer has been formed, a bottom seed structure is formed over the dielectric layer within the recess and the dielectric layer is exposed along sidewalls of the recess. A dummy gate material is grown from the bottom seed structure in a bottom-up deposition process without growing the dummy gate material from the dielectric layer exposed along sidewalls of the recess.
    Type: Application
    Filed: April 21, 2021
    Publication date: October 27, 2022
    Inventors: Chia-Ao Chang, Pei-Ren Jeng, Chii-Horng Li, Yee-Chia Yeo
  • Publication number: 20220294858
    Abstract: Embodiments of this application provide a packet transmission method, a communication apparatus, and a communication system. A target transport layer proxy network element establishes a fourth transport layer connection based on a first context of a source transport layer proxy network element, where the first context is a context about packet transmission of the source transport layer proxy network element on a first path. If the target transport layer proxy network element receives first indication information, and the first indication information indicates that application context migration between a first application server and a second application server is completed, the target transport layer proxy network element performs transport layer processing on a packet on a second path based on a second context of the target transport layer proxy network element, and transmits, on the second path, a packet obtained through the transport layer processing. Hence, a packet loss can be avoided.
    Type: Application
    Filed: May 27, 2022
    Publication date: September 15, 2022
    Inventors: Fang YU, Yan LI, Ao LEI
  • Publication number: 20220264356
    Abstract: The present disclosure provides example traffic routing methods, apparatuses, and systems. One example method includes determining, by a session management network element, a routing rule, where the routing rule indicates a first traffic steering entity to send a first traffic to a first function entity, or send a second traffic to a second function entity or an access device, where the first traffic is a traffic on which first traffic steering control is to be performed, and the second traffic is a traffic on which the first traffic steering control has been performed. The routing rule is sent by the session management network element to the first traffic steering entity in a session management process.
    Type: Application
    Filed: May 6, 2022
    Publication date: August 18, 2022
    Inventors: Yongcui LI, Ao LEI, Hui NI
  • Publication number: 20220220128
    Abstract: (I) Disclosed herein are compounds of formula I, and/or a stereoisomer, a stable isotope, or a pharmaceutically acceptable salt or solvate thereof; and therapeutic uses of these compounds, which are inhibitors of rearranged during transfection (RET), potentially useful in the treatment of RET-associated diseases, such as RET-associated cancers.
    Type: Application
    Filed: June 9, 2020
    Publication date: July 14, 2022
    Inventors: Qun LI, Jintao ZHANG, Shanzhong JIAN, Ao LI, Wen XU
  • Publication number: 20220143001
    Abstract: The present invention provides a novel pan-RAF kinase inhibitor, comprising a compound of formula (I) or a pharmaceutically acceptable salt, solvate, ester, acid, metabolite or prodrug thereof. The present invention also provides a use or method of the compound of formula (I) in the treatment or prevention of a disorder related to the activity of RAF and/or RAS kinase.
    Type: Application
    Filed: March 7, 2019
    Publication date: May 12, 2022
    Applicant: TARAPEUTICS SCIENCE INC.
    Inventors: Qing Song LIU, Jing LIU, Xi Xiang LI, Ao Li WANG, Zi Ping QI, Qing Wang LIU, Zong Ru JIANG, Feng Ming ZOU, Wen Chao WANG, Chen HU, Cheng CHEN, Li WANG
  • Publication number: 20220114497
    Abstract: In some examples, special-purpose machines are provided that facilitate smart copy optimization in a network service or publication system, including software-configured computerized variants of such special-purpose machines and improvements to such variants, and to the technologies by which such special-purpose machines become improved compared to other special-purpose machines that facilitate adding the new features. Such technologies can include special artificial-intelligence (AI), machine-learning (ML), and natural-language-processing (NLP) techniques.
    Type: Application
    Filed: December 22, 2021
    Publication date: April 14, 2022
    Inventors: Pavan Korada, Sunpreet Singh Khanuja, Ao Li
  • Patent number: 11295237
    Abstract: In some examples, special-purpose machines are provided that facilitate smart copy optimization in a network service or publication system, including software-configured computerized variants of such special-purpose machines and improvements to such variants, and to the technologies by which such special-purpose machines become improved compared to other special-purpose machines that facilitate adding the new features. Such technologies can include special artificial-intelligence (AI), machine-learning (ML), and natural-language-processing (NLP) techniques.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: April 5, 2022
    Assignee: Zeta Global Corp.
    Inventors: Pavan Korada, Sunpreet Singh Khanuja, Ao Li
  • Publication number: 20220081445
    Abstract: The present invention relates to a novel molecule with protein tyrosine kinase inhibitory activity, and the synthesis and usage thereof. Specifically, the present invention relates to compound by formula A, pharmaceutically acceptable salts, hydrates or solvates thereof, and the synthesis and usage thereof.
    Type: Application
    Filed: January 16, 2020
    Publication date: March 17, 2022
    Inventors: Zhaoyin WANG, Bing YAO, Yuanshan YAO, Ao LI, Guoqing CAO
  • Patent number: 11245614
    Abstract: Features are disclosed for managing routing rules stored by a routing device and used to manage network traffic in a network. A computing device can receive multiple routing rules corresponding to multiple routing devices in the network. The computing device can use a formal specification and a snapshot to generate a model of the network. The computing device may use the model in order to statically determine the set of possible paths without causing the transmission of data between a routing device and a destination. the computing device may compare the identified routing rules and the possible paths in order to determine excess routing rules. The computing device may remove the excess routing rules from the routing rules for each routing device such that each routing device routes subsequent network traffic based on the updated routing rules.
    Type: Grant
    Filed: December 7, 2020
    Date of Patent: February 8, 2022
    Assignee: Amazon Technologies, Inc.
    Inventors: John David Backes, Samuel Bayless, Daniel William Dacosta, Ao Li
  • Publication number: 20210401376
    Abstract: Systems and methods detect cortical arousal events from a single time-varying ECG signal that is obtained via single-lead ECG. A pre-trained deep neural network transforms the ECG signal into a sequence of cortical-arousal probabilities. The deep neural network includes an inception module, a residual neural network, and a long short-term memory neural network to identify structure in the ECG signal that distinguishes periods of cortical arousal from periods without cortical arousal.
    Type: Application
    Filed: June 30, 2021
    Publication date: December 30, 2021
    Inventors: JANET ROVEDA, SITENG CHEN, AO LI, STUART QUAN, LINDA POWERS
  • Publication number: 20210403466
    Abstract: Provided are a tricyclic compound as shown in formula (I) as a CRTH2 inhibitor, or a pharmaceutically acceptable salt, a tautomer, a stereoisomer or a solvate thereof, and the use thereof in treating diseases related to CRTH2 receptors.
    Type: Application
    Filed: July 21, 2017
    Publication date: December 30, 2021
    Inventors: Bin CHEN, Yuanshan YAO, Yuan CHEN, Ao LI, Ran XU, Zhensheng HUANG, Dongdong TIAN, Hongwei LI, Chengshuai YANG, Jian LI, Shuhui Chen
  • Publication number: 20210231349
    Abstract: Disclosed are a cold storage material and a cold storage type cryogenic refrigerator using same. The cold storage material is tin alloy particles, the content of tin in the tin alloy particle is not less than 40% and not more than 99%, and the cold storage material at least includes one component of bismuth, antimony, silver and gold. The cold storage type cryogenic refrigerator includes a cold storage device, and the cold storage material filled in the cold storage device is tin alloy particles, is lead-free, lowly toxic, easy in spherization and extremely accessible and has a relatively good thermal performance, has properties comparable to those of lead, and has a relatively good heat exchange performance when being used in a cold storage type refrigerator.
    Type: Application
    Filed: August 8, 2018
    Publication date: July 29, 2021
    Applicant: CSIC PRIDE (NANJING) CRYOGENIC TECHNOLOGY CO., LTD.
    Inventors: Zhipo Zhou, Ao Li, Weiwei Zeng, Yuan Tao
  • Publication number: 20210207852
    Abstract: Disclosed are a self-pressure-relief air distribution mechanism and a corresponding cryogenic refrigerator. The self-pressure-relief air distribution mechanism includes an air distribution valve (6) and a rotary valve (7), where a rear face of the air distribution valve (6) is divided into a high-pressure face (66) and a low-pressure face (65), and the high-pressure face (66) and the low-pressure face (65) are hermetically separated by a third sealing ring (b3) that seals the air distribution valve (6) and a cover (2); and the air distribution valve (6) is provided with a pressure-relief hole (61) that axially penetrates an air distribution face (64) and the low-pressure face (65) of the air distribution valve (6), and a low-pressure passage (22) of the cover (2) can communicate with the rear face of the air distribution valve (6) via the pressure-relief hole (61), to guide a low-pressure airflow in the cover (2) to the rear face of the air distribution valve (6).
    Type: Application
    Filed: May 16, 2018
    Publication date: July 8, 2021
    Applicant: CSIC PRIDE (NANJING) CRYOGENIC TECHNOLOGY CO., LTD
    Inventors: Ao Li, Jinhong Ge, Chenxi Xia, Zhipo Zhou
  • Publication number: 20210188868
    Abstract: The present disclosure provides a compound of Formula (I) and/or a stereoisomer, a tautomer, a stable isotope, or a pharmaceutically acceptable salt thereof; and therapeutic uses of these compounds. They are kinase inhibitors potentially useful in the treatment of diseases treatable, such as cancers. Also disclosed herein is a pharmaceutical composition, comprising a compound of Formula (I) and/or a stereoisomer, a tautomer, a stable isotope, or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: May 20, 2019
    Publication date: June 24, 2021
    Inventors: Qun LI, Jintao ZHANG, Shanzhong JIAN, Wen XU, Ao LI
  • Publication number: 20210148610
    Abstract: An air distribution mechanism and a corresponding cryogenic refrigerator are provided. The air distribution mechanism includes an air distribution valve (6) and a rotary valve (7), the air distribution valve (6) includes an air distribution valve main body (6a) and an air distribution valve seat (6b), an air distribution plane (6a3) that is on the air distribution valve main body (6a) and faces away from the air distribution valve seat (6b) protrudes relative to the air distribution valve seat (6b), the air distribution plane (6a3) is tightly attached to a switching plane (73) on the rotary valve (7), and the switching plane (73) protrudes from the rotary valve (7); the air distribution valve (6) is fixedly mounted in a mounting chamber of a cover (2), and the rotary valve (7) is rotatable around a principal rotation axis O of the rotary valve relative to the air distribution valve (6) to switch connection states of an air distribution side flow path and a switching side flow path.
    Type: Application
    Filed: May 16, 2018
    Publication date: May 20, 2021
    Inventors: Ao LI, Jinhong GE, Zhipo ZHOU, Chenxi XIA
  • Publication number: 20200339533
    Abstract: Disclosed herein are compounds of formula I and/or a stereoisomer, stable isotopologue, and/or pharmaceutically acceptable salts thereof; and therapeutic uses of these compounds, which are inhibitors of tryptophan 2, 3-dioxygenase 2 (TDO2) and/or indoleamine 2, 3-dioxygenase 1 (IDO1), potentially useful in the treatment of diseases treatable, such as cancers.
    Type: Application
    Filed: October 19, 2018
    Publication date: October 29, 2020
    Inventors: Jintao Zhang, Wen Xu, Shanzhong Jian, Ao Li, Qun Li
  • Patent number: 10800765
    Abstract: The present application discloses an indole as represented by formula (I) used as a CRTH2 inhibitor, and a pharmaceutically acceptable salt or tautomer of the indole, and an application of same in treating a disease related to a CRTH2 receptor.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: October 13, 2020
    Assignee: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Yuanshan Yao, Bin Chen, Yuan Chen, Ao Li, Ran Xu, Zhensheng Huang, Dongdong Tian, Hongwei Li, Chengshuai Yang, Jian Li, Shuhui Chen
  • Publication number: 20200193322
    Abstract: In some examples, special-purpose machines are provided that facilitate smart copy optimization in a network service or publication system, including software-configured computerized variants of such special-purpose machines and improvements to such variants, and to the technologies by which such special-purpose machines become improved compared to other special-purpose machines that facilitate adding the new features. Such technologies can include special artificial-intelligence (AI), machine-learning (ML), and natural-language-processing (NLP) techniques.
    Type: Application
    Filed: December 14, 2018
    Publication date: June 18, 2020
    Inventors: Pavan Korada, Sunpreet Singh Khanuja, Ao Li
  • Patent number: 10647700
    Abstract: An inhibitor of a wild type and Y641F mutant of human histone methyltransferase EZH2 is provided herein. Particularly, the inhibitor is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. The inhibitor can be used to treat a cancer or precancerous condition related to EZH2 activity.
    Type: Grant
    Filed: January 17, 2018
    Date of Patent: May 12, 2020
    Assignee: TARAPEUTICS SCIENCE INC.
    Inventors: Qingsong Liu, Jing Liu, Fengchao Lv, Chen Hu, Wen Liang Wang, Ao Li Wang, Zi Ping Qi, Xiao Fei Liang, Wen Chao Wang, Tao Ren, Bei Lei Wang, Li Wang
  • Publication number: 20190367482
    Abstract: An inhibitor of a wild type and Y641 F mutant of human histone methyltransferase EZH2 is provided herein. Particularly, the inhibitor is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. The inhibitor can be used to treat a cancer or precancerous condition related to EZH2 activity.
    Type: Application
    Filed: January 17, 2018
    Publication date: December 5, 2019
    Applicant: TARAPEUTICS SCIENCE INC.
    Inventors: Qingsong LIU, Jing LIU, Fengchao LV, Chen HU, Wen Liang WANG, Ao Li WANG, Zi Ping Qi, Xiao Fei LIANG, Wen Chao WANG, Tao REN, Bei Lei WANG, Li WANG